chr5-33951446-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000509381.1(SLC45A2):c.*206T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0293 in 1,602,262 control chromosomes in the GnomAD database, including 3,570 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.058 ( 596 hom., cov: 32)
Exomes 𝑓: 0.026 ( 2974 hom. )
Consequence
SLC45A2
ENST00000509381.1 3_prime_UTR
ENST00000509381.1 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.21
Genes affected
SLC45A2 (HGNC:16472): (solute carrier family 45 member 2) This gene encodes a transporter protein that mediates melanin synthesis. The protein is expressed in a high percentage of melanoma cell lines. Mutations in this gene are a cause of oculocutaneous albinism type 4, and polymorphisms in this gene are associated with variations in skin and hair color. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 5-33951446-A-G is Benign according to our data. Variant chr5-33951446-A-G is described in ClinVar as [Benign]. Clinvar id is 1222285.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.256 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC45A2 | NM_016180.5 | c.1156+108T>C | intron_variant | ENST00000296589.9 | |||
SLC45A2 | NM_001297417.4 | c.*206T>C | 3_prime_UTR_variant | 4/4 | |||
SLC45A2 | NM_001012509.4 | c.1156+108T>C | intron_variant | ||||
SLC45A2 | XM_047417259.1 | c.916+108T>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC45A2 | ENST00000509381.1 | c.*206T>C | 3_prime_UTR_variant | 4/4 | 1 | ||||
SLC45A2 | ENST00000296589.9 | c.1156+108T>C | intron_variant | 1 | NM_016180.5 | P1 | |||
SLC45A2 | ENST00000382102.7 | c.1156+108T>C | intron_variant | 1 | |||||
SLC45A2 | ENST00000510600.1 | c.631+108T>C | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0577 AC: 8782AN: 152140Hom.: 594 Cov.: 32
GnomAD3 genomes
AF:
AC:
8782
AN:
152140
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0588 AC: 14017AN: 238380Hom.: 1138 AF XY: 0.0604 AC XY: 7872AN XY: 130274
GnomAD3 exomes
AF:
AC:
14017
AN:
238380
Hom.:
AF XY:
AC XY:
7872
AN XY:
130274
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0263 AC: 38164AN: 1450000Hom.: 2974 Cov.: 30 AF XY: 0.0299 AC XY: 21547AN XY: 721524
GnomAD4 exome
AF:
AC:
38164
AN:
1450000
Hom.:
Cov.:
30
AF XY:
AC XY:
21547
AN XY:
721524
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0578 AC: 8797AN: 152262Hom.: 596 Cov.: 32 AF XY: 0.0600 AC XY: 4464AN XY: 74454
GnomAD4 genome
AF:
AC:
8797
AN:
152262
Hom.:
Cov.:
32
AF XY:
AC XY:
4464
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
570
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 16, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at